05 Sep
|
Nurix
|
Queensland
Nurix Therapeutics in Brisbane (onsite) is seeking a Scientist I to design and execute in vitro pharmacology studies for Degrader Antibody Conjugates (DACs). You will build the assay cascade from primary screening to mechanistic characterization, and collaborate with discovery biology, conjugation chemistry, DMPK, and automation teams.
The role emphasizes hands-on cell-based assays, data analysis, and communicating results to teams.
#J-18808-Ljbffr
📌 Scientist I – DAC Screening & In Vitro Pharmacology (Queensland)
🏢 Nurix
📍 Queensland